PDT Partners’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,334
Closed -$108K 589
2025
Q4
$108K Buy
+11,334
New +$115K 0.01% 541
2025
Q3
Sell
-41,281
Closed -$251K 700
2025
Q2
$251K Sell
41,281
-109,035
-73% -$818K 0.01% 621
2025
Q1
$1.86M Buy
150,316
+23,113
+18% +$327K 0.13% 266
2024
Q4
$1.76M Buy
127,203
+16,549
+15% +$261K 0.16% 235
2024
Q3
$1.85M Buy
110,654
+7,946
+8% +$171K 0.16% 225
2024
Q2
$2.12M Buy
+102,708
New +$2.22M 0.2% 189
2021
Q4
Sell
-4,420
Closed -$315K 990
2021
Q3
$315K Buy
+4,420
New +$275K 0.02% 585
2020
Q3
Sell
-39,000
Closed -$408K 835
2020
Q2
$408K Buy
39,000
+17,500
+81% +$194K 0.03% 461
2020
Q1
$230K Hold
21,500
0.02% 530
2019
Q4
$340K Sell
21,500
-15,888
-42% -$170K 0.02% 507
2019
Q3
$293K Sell
37,388
-18,415
-33% -$164K 0.02% 377
2019
Q2
$590K Sell
55,803
-3,100
-5% -$31.8K 0.03% 294
2019
Q1
$714K Buy
+58,903
New +$735K 0.04% 284
2014
Q3
Sell
-57,331
Closed -$1.29M 1532
2014
Q2
$1.29M Buy
+57,331
New +$1.43M 0.03% 603

Other funds holding PRTA

PDT Partners's PRTA Position: Q1 2026 in Review

PDT Partners sold out of Prothena Corp (PRTA) in Q1 2026, closing a stake of 11,334 shares — an estimated $108K sold.

PDT Partners first reported a position in PRTA in Q2 2014 and held it in 14 quarters. The position peaked at $2.12M in Q2 2024. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • PDT Partners reported no remaining Prothena Corp position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 11,334 Prothena Corp shares in Q1 2026, an estimated $108K.
  • PDT Partners first reported a position in Prothena Corp in Q2 2014 and held it in 14 quarters.
  • PDT Partners's Prothena Corp position peaked at $2.12M in Q2 2024.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.